Back to TCRX
JANE STREET GROUP, LLC TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$9K
Q3 2026
Peak value
$269K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $69K |
| Q3 2025 | $79K |
| Q4 2025 | $269K |
| Q4 2025 | $119K |
| Q1 2026 | $80K |
| Q1 2026 | $66K |
| Q2 2026 | $206K |
| Q2 2026 | $30K |
| Q3 2026 | $19K |
| Q3 2026 | $9K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9K | 29.8K | — | — |
| Q3 2026 | $19K | 60.4K | — | — |
| Q2 2026 | $30K | 30.9K | — | — |
| Q2 2026 | $206K | 210.6K | — | — |
| Q1 2026 | $66K | 65.5K | — | — |
| Q1 2026 | $80K | 78.9K | — | — |
| Q4 2025 | $119K | 119.4K | — | — |
| Q4 2025 | $269K | 268.9K | — | — |
| Q3 2025 | $79K | 43.3K | — | — |
| Q3 2025 | $69K | 38.0K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M